Does not appear to be any update for the sepsis or Covid/Flu A/Flu B space in the Report. That concerns me, as the life sciences update seems to be more geared towards to acquisitions rather than development of new tests.
EDIT: "Cessation and realignment of resources from existing clinical developments (COVID-19, Multiplex, PCT) to assay development, due to regulatory and market conditions."
- Forums
- ASX - By Stock
- ADO
- Ann: Company Update
Ann: Company Update, page-2
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $65.97M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $12.09K | 448.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 648153 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 35520 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 648153 | 0.026 |
13 | 2077099 | 0.025 |
6 | 1339250 | 0.024 |
4 | 1110217 | 0.023 |
5 | 1386450 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 35520 | 1 |
0.028 | 251200 | 3 |
0.030 | 234200 | 2 |
0.031 | 75000 | 1 |
0.032 | 191382 | 2 |
Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |